Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study.
Jon Salmanton-GarcíaOliver A CornelyJannik StemlerAleksandra BaraćJörg SteinmannAlena SivákováEmin Halis AkalinSevtap Arikan-AkdagliLaura LoughlinCristina ToscanoManjusha NarayananBenedict RogersBirgit WillingerDeniz AkyolEmmanuel RoilidesKatrien LagrouMalgorzata MikulskaBlandine DenisDiane PonscarmeUrlike ScharmannAlpay AzapDeborah LockhartTihana BicanicFlorian KronNurettin ErbenRiina Rautemaa-RichardsonAnna L GoodmanCarolina Garcia-VidalCornelia Lass-FlörlJean-Pierre GangneuxLucia TaramassoMaite RuizYael SchickEric Van WijngaerdenChristopher MilacekDaniele Roberto GiacobbeClare LoganEmily RooneyAndrea GoriMurat AkovaMatteo BassettiMartin HoeniglPhilipp KoehlerPublished in: The Journal of infection (2024)
Although overall and attributable mortality in this subgroup analysis of matched case/control pairs remains high, the attributable mortality appears to have decreased in comparison to historical cohorts. This decrease may be driven by improved prognosis of Candida albicans and Candida parapsilosis candidemia; whereas candidemia due to other Candida spp. exhibits a much higher attributable mortality.